Merck & Co., Inc. (MRK) News Today → Proof that the Musk/Bezos rivalry is about to hit a new level (From InvestorPlace) (Ad) Free MRK Stock Alerts $129.89 +0.34 (+0.26%) (As of 11:21 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMerck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Radiotherapy, for Patients With Newly Diagnosed, High-Risk Endometrial Cancer After Surgery With Curative Intentfinance.yahoo.com - May 9 at 10:30 AMHealth Canada Approves KEYTRUDA® for adult patients with locally advanced unresectable or metastatic biliary tract carcinoma, in combination with gemcitabine-based chemotherapyfinance.yahoo.com - May 9 at 10:30 AMHi Line Capital Management LLC Has $8.73 Million Stock Position in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - May 9 at 9:56 AMMerck & Co., Inc. Q1 Earnings Transcriptmarketbeat.com - May 9 at 7:05 AMMerck treatment for a type of uterus cancer fails trialreuters.com - May 9 at 6:57 AMWealthspire Advisors LLC Lowers Holdings in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - May 9 at 12:46 AMMerck & Co., Inc.: Merck Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through Merck for Mothersfinanznachrichten.de - May 8 at 10:40 AMMerck Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through Merck for Mothersfinance.yahoo.com - May 8 at 10:40 AMQ1 2024 OPKO Health Inc Earnings Callfinance.yahoo.com - May 8 at 7:07 AMMerck to Participate in the Bank of America Securities 2024 Healthcare Conferencebusinesswire.com - May 8 at 6:45 AMCullen Frost Bankers Inc. Has $36.21 Million Stake in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - May 8 at 12:48 AMWelch & Forbes LLC Trims Stock Holdings in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - May 6 at 11:55 PMMerck Q1: There's Still Room For Growthseekingalpha.com - May 6 at 5:27 PMMerck First Quarter 2024 Earnings: Beats Expectationsfinance.yahoo.com - May 6 at 7:01 AMPress Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Regionglobenewswire.com - May 6 at 1:00 AMMetis Global Partners LLC Has $15.87 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - May 6 at 12:25 AMMerck & Co., Inc. (NYSE:MRK) Shares Down 0.8% americanbankingnews.com - May 5 at 6:22 AMRiver Global Investors LLP Makes New Investment in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - May 4 at 6:59 PMLos Angeles Capital Management LLC Boosts Stock Position in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - May 3 at 10:25 PMFifth Third Bancorp Has $116.35 Million Position in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - May 3 at 12:33 AMMerck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expirationfinance.yahoo.com - May 2 at 3:56 PMFirst Trust Direct Indexing L.P. Has $4.47 Million Holdings in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - May 1 at 7:21 PMMerck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival (OS) as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinomafinance.yahoo.com - May 1 at 7:49 AMIs Merck Stock Fully Valued At $130?forbes.com - May 1 at 6:14 AMRaymond James Financial Services Advisors Inc. Has $471.70 Million Position in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - May 1 at 12:50 AMMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - April 30 at 12:59 PMKestra Private Wealth Services LLC Purchases 12,477 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 29 at 9:50 PMMerck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adultsbusinesswire.com - April 29 at 9:00 AMFY2024 Earnings Estimate for Merck & Co., Inc. (NYSE:MRK) Issued By Cantor Fitzgeraldamericanbankingnews.com - April 29 at 3:16 AMLeerink Partnrs Analysts Cut Earnings Estimates for Merck & Co., Inc. (NYSE:MRK)americanbankingnews.com - April 29 at 1:42 AMBlue Chip Partners LLC Raises Stock Position in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 28 at 10:25 PMMerck & Co., Inc. (NYSE:MRK) Shares Acquired by PFG Investments LLCmarketbeat.com - April 27 at 9:58 PMMerck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Thinkfinance.yahoo.com - April 27 at 10:02 AMTruist Financial Corp Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 27 at 12:41 AMMerck & Co., Inc. (NYSE:MRK) Announces Quarterly Earnings Results, Beats Estimates By $0.13 EPSmarketbeat.com - April 26 at 3:51 PMTruist Financial Boosts Merck & Co., Inc. (NYSE:MRK) Price Target to $143.00marketbeat.com - April 26 at 12:52 PMBank Julius Baer & Co. Ltd Zurich Sells 1,166,230 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 25 at 8:21 PMMerck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlookbenzinga.com - April 25 at 12:55 PMHeard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharmafinance.yahoo.com - April 25 at 12:55 PMMerck's Cancer Drug and Vaccine Sales Drive Better-Than-Expected Resultsinvestopedia.com - April 25 at 11:36 AMMerck jumps on profit beat as Bristol Myers Squibb slips to a lossproactiveinvestors.com - April 25 at 9:51 AMMerck & Co., Inc. (NYSE:MRK) Issues FY24 Earnings Guidancemarketbeat.com - April 25 at 9:25 AMMerck’s first-quarter results beat expectations amid healthy vaccine-sales growthmarketwatch.com - April 25 at 7:55 AMMerck Lifts FY24 Outlook After Higher Q1 Earnings, Above Market; Stock Up In Pre-marketmarkets.businessinsider.com - April 25 at 7:55 AMMerck raises 2024 profit forecast on strong sales of cancer drug Keytrudafinance.yahoo.com - April 25 at 7:55 AMUPDATE 1-Merck raises 2024 profit forecast on strong sales of cancer drug Keytrudafinance.yahoo.com - April 25 at 7:55 AMMerck & Co., Inc. (NYSE:MRK) Releases FY 2024 Earnings Guidancemarketbeat.com - April 25 at 7:24 AMMerck raises 2024 profit forecast on strong cancer, HPV drugs salesreuters.com - April 25 at 6:33 AMMerck beats earnings expectations, raises outlook on strong Keytruda and vaccine salescnbc.com - April 25 at 6:32 AMMerck Announces First-Quarter 2024 Financial Resultsbusinesswire.com - April 25 at 6:30 AM Get Merck & Co., Inc. News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Things Are Not Normal in America – Here’s What to Do (Ad)Get Out of the Dollar Before May 15 A Wall Street legend and our friend has just warned 896,000 Americans to prepare for May 15. This could be your solution. MRK Media Mentions By Week MRK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRK News Sentiment▼0.760.36▲Average Medical News Sentiment MRK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRK Articles This Week▼2115▲MRK Articles Average Week Get Merck & Co., Inc. News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Johnson & Johnson News AbbVie News Pfizer News Bristol-Myers Squibb News Eli Lilly and Company News AstraZeneca News Novartis News Abbott Laboratories News Sanofi News Vertex Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MRK) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck & Co., Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.